Use este identificador para citar ou linkar para este item: https://ri.ufs.br/jspui/handle/riufs/1687
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorAndrade, Tâmara Natasha Gonzaga de-
dc.contributor.authorSilvestre, Carina Carvalho-
dc.contributor.authorCunha, Luiza Correia-
dc.contributor.authorSilva, Daniel Tenório da-
dc.contributor.authorMarques, Tatiane Cristina-
dc.contributor.authorOliveira Filho, Alfredo Dias de-
dc.contributor.authorLyra Junior, Divaldo Pereira de-
dc.date.accessioned2016-03-07T23:10:48Z-
dc.date.available2016-03-07T23:10:48Z-
dc.date.issued2015-01-
dc.identifier.citationANDRADE, T. N. G. et al. Pharmaceutical intervention assessment in the identification and management of drug interactions in an intensive care unit. Journal of Applied Pharmaceutical Science, v. 5, n. 1, jan. 2015. Disponível em: <http://www.scopemed.org/?mno=159293>. Acesso em: 07 mar. 2016.pt_BR
dc.identifier.issn2231-3354-
dc.identifier.urihttps://ri.ufs.br/handle/riufs/1687-
dc.description.abstractIt is estimated there are thousands of combinations of drugs, which may generate various adverse drug events, including drug interactions (DI). To assess the contribution of pharmacist to identification and management of DI in an intensive care unit (ICU). A longitudinal study was conducted in the ICU of a private hospital in the city of Aracaju-SE, between 2008 and 2009. The prevalence and clinical relevance of DI was assessed by two clinical pharmacists. Demographic data and clinical information of patients hospitalized in the period of the study were obtained from medical records. At the end of the study 137 medical records were analyzed, with a predominance of female patients (55.4%), average age of 66 (±7.0) years. 6,085 prescriptions were collected during the study period, in which 2,455 drugs prescribed. Of these, 175 prescriptions contained clinically relevant DI, 178 of moderate severity and 35 of major severity, 213 DI in total. The clinical pharmacists prepared reports for the physicians, which enabled the reduction of 40% of all DI. Data from this study suggest that pharmacist’s contribution may have reduced the incidence of DI, providing more familiarity of physicians on clinically relevant information and improving the quality of prescriptions in the ICU.pt_BR
dc.language.isoenpt_BR
dc.publisherOpen Science Publishers LLPpt_BR
dc.subjectDrug interactionspt_BR
dc.subjectPharmacistspt_BR
dc.subjectHospitalspt_BR
dc.subjectInterações medicamentosaspt_BR
dc.subjectFarmacêuticospt_BR
dc.subjectHospitaispt_BR
dc.titlePharmaceutical intervention assessment in the identification and management of drug interactions in an intensive care unitpt_BR
dc.typeArtigopt_BR
dc.identifier.licenseCreative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported Licensept_BR
Aparece nas coleções:DFAL - Artigos de periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
PharmaceuticalInterventionManagement.pdf106,16 kBAdobe PDFThumbnail
Visualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.